Osborne Partners Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,330
Closed -$1.7M 221
2020
Q4
$1.7M Buy
+11,330
New +$1.6M 0.21% 97
2019
Q1
Sell
-11,433
Closed -$1.15M 184
2018
Q4
$1.15M Hold
11,433
0.17% 105
2018
Q3
$1.46M Buy
11,433
+103
+0.9% +$12.2K 0.19% 101
2018
Q2
$1.23M Hold
11,330
0.17% 103
2018
Q1
$1.2M Hold
11,330
0.17% 103
2017
Q4
$1.33M Hold
11,330
0.18% 103
2017
Q3
$1.29M Hold
11,330
0.18% 106
2017
Q2
$1.41M Hold
11,330
0.2% 98
2017
Q1
$1.34M Hold
11,330
0.19% 103
2016
Q4
$1.14M Hold
11,330
0.17% 107
2016
Q3
$1.43M Sell
11,330
-82
-0.7% -$10.1K 0.21% 97
2016
Q2
$1.33M Sell
11,412
-371
-3% -$42K 0.2% 100
2016
Q1
$1.22M Hold
11,783
0.18% 103
2015
Q4
$1.17M Hold
11,783
0.17% 106
2015
Q3
$1.07M Sell
11,783
-1,648
-12% -$165K 0.16% 108
2015
Q2
$1.42M Buy
13,431
+824
+7% +$91.2K 0.19% 103
2015
Q1
$1.44M Hold
12,607
0.19% 106
2014
Q4
$1.39M Hold
12,607
0.17% 107
2014
Q3
$1.23M Sell
12,607
-561
-4% -$55.2K 0.16% 107
2014
Q2
$1.33M Buy
13,168
+1,385
+12% +$135K 0.17% 102
2014
Q1
$1.08M Hold
11,783
0.14% 113
2013
Q4
$1.07M Hold
11,783
0.14% 111
2013
Q3
$940K Hold
11,783
0.13% 109
2013
Q2
$857K Buy
+11,783
New +$881K 0.12% 116

Other funds holding ZBH

Osborne Partners Capital Management's ZBH Position: Q1 2021 in Review

Osborne Partners Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 11,330 shares — an estimated $1.7M sold.

Osborne Partners Capital Management first reported a position in ZBH in Q2 2013 and held it in 24 quarters. The position peaked at $1.7M in Q4 2020. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Osborne Partners Capital Management reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Osborne Partners Capital Management sold 11,330 Zimmer Biomet shares in Q1 2021, an estimated $1.7M.
  • Osborne Partners Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 24 quarters.
  • Osborne Partners Capital Management's Zimmer Biomet position peaked at $1.7M in Q4 2020.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Osborne Partners Capital Management's 13F filing for Q1 2021, filed 27 Apr 2021.